Biotronik announced the Japanese market release of Renamic, their next-generation programmer for implantable devices used in cardiac rhythm management.
Renamic, the newest addition to Biotronik’s portfolio of external devices, is used for programming, reprogramming and testing of implantable pacemakers, implantable cardiac defibrillators (ICDs) and cardiac resynchronisation therapy (CRT) devices.
“Renamic starts a new era for convenient programming and follow-up of Biotronik cardiac devices and improves daily clinic efficiency,” commented Werner Braun, managing director, Biotronik. “The growth of cardiac electrophysiology in Japan is significant, and Biotronik is committed to investing in support of this high potential market”,
The launch of the Renamic in the Japanese market offers significant advantages with regards to helping optimise in-clinic patient care and cardiac implantable device function. The new device’s features provide valuable benefits, such as:
- An intuitive user interface optimised to increase the efficiency of patient follow-up.
- A tested and proven printer from a renowned printer manufacturer.
- A retractable and adjustable touchscreen for optimised viewing and handling.
Easy to handle for efficient and versatile usage, the Renamic’s new user interface has been optimised with improved use of spacing and an intuitive color-coding. The touchscreen can either be used with the stylus pen or with any other tool.
“We are pleased to be able to provide Renamic for cardiac clinical teams in Japan. Its easy handling will improve the user’s experience as well as potentially save time and cost”, commented Jeffrey Annis, managing director, Biotronik Japan. “Renamic starts a new era for convenient programming and follow-up of Biotronik cardiac devices and improves daily clinic efficiency.”